XARACOLL Drug Patent Profile

✉ Email this page to a colleague

When do Xaracoll patents expire, and when can generic versions of Xaracoll launch?

Xaracoll is a drug marketed by Innocoll Pharms and is included in one NDA. There are two patents protecting this drug.

This drug has eighty patent family members in twenty-three countries.

The generic ingredient in XARACOLL is bupivacaine hydrochloride. There are twelve drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the bupivacaine hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Xaracoll

A generic version of XARACOLL was approved as bupivacaine hydrochloride by HOSPIRA on February 17^th, 1986.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for XARACOLL?
What are the global sales for XARACOLL?
What is Average Wholesale Price for XARACOLL?

Summary for XARACOLL

International Patents:	80
US Patents:	2
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	125
Clinical Trials:	4
Patent Applications:	4,349
What excipients (inactive ingredients) are in XARACOLL?	XARACOLL excipients list
DailyMed Link:	XARACOLL at DailyMed

Drug patent expirations by year for XARACOLL

Recent Clinical Trials for XARACOLL

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Cmed	Phase 3
Premier Research Group plc	Phase 3
Innocoll	Phase 3

See all XARACOLL clinical trials

US Patents and Regulatory Information for XARACOLL

XARACOLL is protected by two US patents.

Patents protecting XARACOLL

Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Drug delivery device for providing local analgesia, local anesthesia or nerve blockage
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: A METHOD FOR INDUCING A POST-SURGICAL ANALGESIA SPARING EFFECT BY IMPLANTING AT THE SURGICAL SITE A COLLAGEN SPONGE CONTAINING BUPIVACAINE HCL WHICH PROVIDES LOCAL ANESTHESIA FOR UP TO 24 HOURS FOLLOWING IMPLANTATION

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Innocoll Pharms	XARACOLL	bupivacaine hydrochloride	IMPLANT;IMPLANTATION	209511-001	Aug 28, 2020		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Innocoll Pharms	XARACOLL	bupivacaine hydrochloride	IMPLANT;IMPLANTATION	209511-001	Aug 28, 2020		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for XARACOLL

See the table below for patents covering XARACOLL around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Portugal	2139457		⤷ Sign Up
Turkey	201905174		⤷ Sign Up
Ireland	20070220	A drug delivery device for providing local analgesia, local anesthesia or nerve blockade	⤷ Sign Up
Eurasian Patent Organization	027745	МОДИФИЦИРОВАННЫЙ КОЛЛАГЕН (MODIFIED COLLAGEN)	⤷ Sign Up
Norway	2802624		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for XARACOLL

Recent Clinical Trials for XARACOLL

Patents protecting XARACOLL

Make Better Decisions: Try a trial or see plans & pricing